bpc-157 and thymosin beta 4 BPC 157 vs TB 500 — Research Peptide Comparison TB 500 vs BPC 157:

Main Phase (Baseline to Week 26): Study 1 (NCT 00123253) This study randomized 412 HIV-infected patients with lipodystrophy and excess abdominal fat to receive either a 2 mg dose of EGRIFTA (1 mg/vial formulation) (N=273) or placebo (N=137)

What it targets is inflammation and tissue repair and those pathways matter significantly in PMOS

We are the most trusted provider of online prescriptions with medications sourced from US compounding pharmacies

It also helps to form myelin sheath to protect nerve cells and conduct nerve impulses, and lowers homocysteine levels thereby reducing the risk of strokes or heart attacks